Drug Type Small molecule drug |
Synonyms HA-5-fluorouracil, Hyaluronan acid-5-fluorouracil complex, Hyaluronic acid-5-fluorouracil complex + [2] |
Target |
Mechanism CD44 modulators(CD44 antigen modulators), TYMS inhibitors(Thymidylate synthase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC4H3FN2O2 |
InChIKeyGHASVSINZRGABV-UHFFFAOYSA-N |
CAS Registry51-21-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Phase 2 | AU | - | |
Colorectal Cancer | Phase 2 | - | - | |
Colorectal Cancer | Phase 2 | - | - |
Phase 2 | 50 | Proton Beam Radiation+Leucovorin Calcium+irinotecan+Losartan+oxaliplatin+Irinotecan hydrochloride+FLUOROURACIL | wqalmzjknp(qdfuclocpj) = ltxcwbacja dewqpmptdv (rvnfosdwkz, rntvvlgosu - axnvjfhzrl) View more | - | 17 Sep 2019 | ||
Phase 2 | 135 | Radiation+5FU (Good Risk (Thymidylate Synthase (TYMS)*2/*2, *2/*3, *2/*4)) | wrrpjkvpsl(lbhyaolmwp) = blxyjdlyor zzadrkinuh (cigqtlpjgi, kfhwwaekdg - erkudkpfao) View more | - | 08 Sep 2014 | ||
(Poor Risk (Thymidylate Synthase (TYMS)*3/*3, *3/*4)) | wrrpjkvpsl(lbhyaolmwp) = zbowaevmyi zzadrkinuh (cigqtlpjgi, toxokvmryj - emckauozkh) View more |